<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>European drugmakers say they are ‘losing ground’ to US and Chinese rivals — Live Feed</title><link>https://www.live-feeds.com/feed/european-drugmakers-say-they-are-losing-ground-to-us-and-chinese-rivals</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/european-drugmakers-say-they-are-losing-ground-to-us-and-chinese-rivals/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Nine European Pharma Chairs Warn of Investment Decline</title><link>https://www.live-feeds.com/feed/european-drugmakers-say-they-are-losing-ground-to-us-and-chinese-rivals</link><guid isPermaLink="false">https://www.live-feeds.com/feed/european-drugmakers-say-they-are-losing-ground-to-us-and-chinese-rivals#u83141</guid><pubDate>Fri, 25 Sep 2026 00:10:50 +0000</pubDate><description>The chairs of nine major pharmaceutical companies warn that Europe is losing ground to rivals in the US and China. In an open letter, leaders from firms including AstraZeneca, Novartis, and Roche state that the region is losing the investment race. They are calling for increased spending and faster clinical trials to strengthen innovation. The executives warn European leaders that future investment is at risk unless the bloc takes urgent action to reverse a perceived slow agony of decline.Why it mattersPharmaceutical innovation requires massive capital and rapid regulatory approval to remain c</description></item>
</channel></rss>